RMR Wealth Builders’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.96M Buy
39,220
+25,336
+182% +$3.34M 0.31% 52
2026
Q1
$1.94M Buy
13,884
+62
+0.4% +$8.68K 0.15% 82
2025
Q4
$1.7M Buy
13,822
+536
+4% +$65.1K 0.14% 84
2025
Q3
$1.47M Buy
13,286
+316
+2% +$35.9K 0.12% 90
2025
Q2
$1.44M Buy
12,970
+480
+4% +$51.1K 0.13% 93
2025
Q1
$1.4M Buy
12,490
+2,117
+20% +$218K 0.15% 88
2024
Q4
$958K Sell
10,373
-14
-0.1% -$1.26K 0.1% 111
2024
Q3
$871K Buy
10,387
+40
+0.4% +$3.05K 0.09% 112
2024
Q2
$710K Sell
10,347
-650
-6% -$43.4K 0.08% 123
2024
Q1
$806K Sell
10,997
-96
-0.9% -$7.38K 0.1% 114
2023
Q4
$899K Buy
11,093
+69
+0.6% +$5.37K 0.13% 93
2023
Q3
$826K Sell
11,024
-59
-0.5% -$4.54K 0.13% 84
2023
Q2
$854K Buy
11,083
+31
+0.3% +$2.47K 0.15% 72
2023
Q1
$917K Sell
11,052
-28
-0.3% -$2.32K 0.17% 69
2022
Q4
$951K Sell
11,080
-1,529
-12% -$121K 0.22% 55
2022
Q3
$778K Sell
12,609
-29
-0.2% -$1.83K 0.19% 60
2022
Q2
$781K Buy
+12,638
New +$782K 0.19% 75
2021
Q2
Sell
-496
Closed -$32K 361
2021
Q1
$32K Sell
496
-401
-45% -$25.9K 0.01% 438
2020
Q4
$52K Buy
+897
New +$54.1K 0.03% 257
2020
Q3
Sell
-394
Closed -$30K 315
2020
Q2
$30K Buy
+394
New +$30.2K 0.03% 272
2019
Q4
$50K Buy
+762
New +$49.6K 0.05% 229

Other funds holding GILD

RMR Wealth Builders's GILD Position: Q2 2026 in Review

RMR Wealth Builders increased its Gilead Sciences (GILD) stake by 182% in Q2 2026, buying an estimated $3.34M and bringing the position to 39,220 shares worth $4.96M. The position accounts for 0.31% of the portfolio, ranked #52.

RMR Wealth Builders first reported a position in GILD in Q4 2019 and has held it in 21 quarters since. 734 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • RMR Wealth Builders held 39,220 shares of Gilead Sciences worth $4.96M as of Q2 2026.
  • RMR Wealth Builders bought 25,336 Gilead Sciences shares in Q2 2026, an estimated $3.34M.
  • Gilead Sciences made up 0.31% of RMR Wealth Builders's portfolio in Q2 2026, its #52 holding.
  • RMR Wealth Builders first reported a position in Gilead Sciences in Q4 2019 and has held it in 21 quarters since.
  • 734 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on RMR Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.